Policy on related-party transactions
Its update has been approved at the Board of Directors' meeting held on 3 May 2024.
Policy on director diversity in the composition of the Board of Directors
Approved at the Board of Directors' meeting held on 11 December 2020.
Internal code of conduct for matters relating to the stock markets
At its meeting held on 28 October 2016, the Board of Directors approved the Internal Code of Conduct in Matters Related to the Spanish Stock Market.
Risk control and management policy
Approved at the Board of Directors' meeting held on 11 December 2020.
Policy on Comunication and contacts with stakeholders, institutional investors and proxy advisors
Approved at the Board of Directors' meeting held on 11 December 2020.
Tax compliance and best practices
Crime prevention policy
Conflicts of interest policy
Approved at the Board of Directors' meeting held on 22 October 2024.
Sustainability policy
Approved at the Board of Directors' meeting held on 11 December 2020.
Human Rights Policy
Approved at the Board of Directors' meeting held on 25 February 2022.
Plasma Donor Policy
Approved at the Board of Directors' meeting held on 25 February 2022.
Patient and Patient Organizations Policy
Approved at the Board of Directors' meeting held on 25 February 2022.
Climate action policy
Approved at the Board of Directors' meeting held on 23 February 2023.
Mental Health policy
Approved at the Board of Directors' meeting held on 23 February 2023.
Clawback policy
Approved at the Board of Directors’ meeting held on 19 October 2023.
Cybersecurity Policy
Approved at the Board of Directors’ meeting held on 16 November 2023
Grifols Ethics Line Policy
Approved at the Board of Directors' meeting held on 18 December 2023.
Policy available in other languages
Biodiversity Policy
Approved at the Board of Directors' meeting held on April 17, 2024.